v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities:    
Net loss $ (26,956) $ (23,088)
Adjustments to reconcile net loss to cash used in operating activities:    
Depreciation and amortization 8,379 8,709
Unrealized gain on foreign currency (53) (780)
Stock-based compensation 3,102 2,703
Change in fair value of warrants (7) (982)
Amortization of debt discount and deferred issuance costs 544 6,643
Deferred income tax 29 120
Provision for credit losses (477) (152)
Non-cash portion of early termination on lease 1,259 0
Non-cash lease expense 7,275 9,637
Changes in operating assets and liabilities:    
Accounts receivable 16,463 13,787
Prepaid expenses and other current assets and prepaid expenses and other assets (3,746) (3,990)
Film costs 691 0
Accounts payable (2,409) (5,384)
Accrued compensation (239) 45
Accrued expenses, other current liabilities, and other liabilities (1,096) (5,215)
Lease liabilities (9,486) (12,078)
Deferred revenue 1,427 1,270
Cash used in operating activities (5,300) (8,755)
Investing activities:    
Capital expenditures (313) (834)
Capitalization of internal-use software (6,890) (6,349)
Business combinations, net of cash acquired 0 (233)
Proceeds from sale of asset 75 300
Cash used in investing activities (7,128) (7,116)
Financing activities:    
Borrowings from Term Loan 0 39,175
Borrowings from film financing arrangements 621 2,402
Proceeds from co-financing arrangements for feature films 0 1,200
Proceeds from issuance of common stock in connection with Stock Purchase Agreement, net of issuance costs 19,400 0
Proceeds from private placements 6,072 0
Proceeds from exercise of stock options 0 16
Payment on Convertible Notes 0 (30,000)
Payment of consent solicitation fees 0 (2,089)
Payment on Term Loan (20,000) 0
Payment of Term Loan's debt issuance / modification costs (959) (687)
Payment of film financing arrangements for feature films (378) 0
Repurchase of common stock 0 (3,332)
Payment for shares withheld for employee taxes (136) (125)
Payment of at-the-market offering issuance costs, net (69) (115)
Cash provided by financing activities 4,551 6,445
Effect of currency translation on cash and cash equivalents (39) 484
Net decrease in cash and cash equivalents (7,916) (8,942)
Cash and cash equivalents and restricted cash at beginning of period 27,739 38,648
Cash and cash equivalents and restricted cash at end of period $ 19,823 $ 29,706